These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8823593)

  • 21. The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy.
    Ciulla TA; Rutledge BK; Morley MG; Duker JS
    Ophthalmic Surg Lasers; 1998 Mar; 29(3):198-206. PubMed ID: 9547773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
    Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
    Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraocular therapy for cytomegalovirus retinitis.
    Palestine AG
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy.
    Ries E; Mühlbauer B; Ruhswurm I; Krepler K; Derbolav A; Svolba G; Rieger A; Wedrich A
    Ophthalmologica; 1998; 212(4):239-43. PubMed ID: 9672212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytomegalovirus retinitis].
    Usui N; Usui M
    Nihon Rinsho; 1998 Jan; 56(1):197-202. PubMed ID: 9465690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macular CMV retinitis: a case report.
    Demols P; Claes CA; Farber CM; Rasquin F
    Bull Soc Belge Ophtalmol; 2004; (293):17-21. PubMed ID: 15510719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current management of cytomegalovirus retinitis in AIDS update on ganciclovir and foscarnet for CMV infections.
    Jacobson MA
    Adv Exp Med Biol; 1996; 394():85-92. PubMed ID: 8815712
    [No Abstract]   [Full Text] [Related]  

  • 28. Cytomegalovirus retinitis: diagnosis and status of systemic therapy.
    Friedberg DN
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S1-6. PubMed ID: 9058611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS.
    Plosker GL; Noble S
    Drugs; 1999 Aug; 58(2):325-45. PubMed ID: 10473024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New treatment options for CMV retinitis in AIDS.
    Lalezari JP
    Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896
    [No Abstract]   [Full Text] [Related]  

  • 31. Local therapy for cytomegalovirus retinitis.
    Smith CL
    Ann Pharmacother; 1998 Feb; 32(2):248-55. PubMed ID: 9496411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Support for new foscarnet indication for AIDS-related CMV retinitis is mixed.
    AIDS Patient Care STDS; 1997 Oct; 11(5):377. PubMed ID: 11361828
    [No Abstract]   [Full Text] [Related]  

  • 34. Chronic retinal necrosis: cytomegalovirus necrotizing retinitis associated with panretinal vasculopathy in non-HIV patients.
    Schneider EW; Elner SG; van Kuijk FJ; Goldberg N; Lieberman RM; Eliott D; Johnson MW
    Retina; 2013 Oct; 33(9):1791-9. PubMed ID: 23584702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival differences associated with treatment of cytomegalovirus retinitis in Maryland patients with AIDS, 1987-1994.
    Wutoh AK; Hidalgo J; Rhee W; Bareta J; Steidl S
    Am J Health Syst Pharm; 1999 Jul; 56(13):1314-8. PubMed ID: 10683128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS.
    Jabs DA; Martin BK; Forman MS;
    Ophthalmology; 2010 Jan; 117(1):128-132.e2. PubMed ID: 19818505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Jacobson MA; Wulfsohn M; Feinberg JE; Davis R; Power M; Owens S; Causey D; Heath-Chiozzi ME; Murphy RL; Cheung TW
    AIDS; 1994 Apr; 8(4):451-9. PubMed ID: 8011248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic management of cytomegalovirus retinitis: review of current and future therapeutic modalities.
    Bright DC
    J Am Optom Assoc; 1997 Jan; 68(1):11-30. PubMed ID: 9037986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS.
    Vitravene Study Group
    Am J Ophthalmol; 2002 Apr; 133(4):467-74. PubMed ID: 11931780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical vs photographic assessment of treatment of cytomegalovirus retinitis. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial Report 8. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group.
    Arch Ophthalmol; 1996 Jul; 114(7):848-55. PubMed ID: 8660169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.